Alcidion: Building Digital Health Momentum Through Major NHS Wins, Defence Partnerships and Expanding Platform Reach
Alcidion has spent years trying to position Miya Precision as more than a hospital software tool, and FY25 suggests that proposition is gaining meaningful commercial traction. The company says its purpose is to transform healthcare with smart, intuitive technology, and describes Miya Precision as a platform that addresses challenges such as patient flow, clinical workflow, modern modular EPR and virtual care across multiple jurisdictions. In plain terms, Alcidion is trying to sit at the orchestration layer of healthcare operations rather than sell one isolated point solution.
The financial picture in FY25 was strong enough to support that ambition. Alcidion reported FY25 revenue of $40.8 million, up 10% year on year, annual recurring product revenue of $26.0 million, ARR of about $28.5 million, EBITDA of $4.8 million, a cash balance of $17.7 million and no debt. Its FY25 materials also said the company delivered positive operating cash flow and had over $140 million in contracted and renewal revenue secured from FY26 to FY30.
What makes the story especially compelling is the size and quality of the recent contract wins. Alcidion’s FY25 annual-report commentary said the company secured a record $73.8 million in new contract value during the year, highlighted by its largest ever single contract: a $37.5 million, 10-year partnership with North Cumbria Integrated Care NHS Foundation Trust. That is a significant milestone because it validates Miya Precision not just as a workflow enhancer, but as a long-duration strategic platform inside a major health network.
North Cumbria is also a useful example of how Alcidion’s modular strategy works. The trust chose Miya Precision as its preferred EPR platform, and later expanded the relationship to add MediViewer from partner Mizaic, allowing scanned and historical documents to be accessed inside the Miya Precision workflow. That is an important collaborator detail because it shows Alcidion winning not by insisting everything be native, but by making third-party capability work inside a broader digital-care architecture.
The same interoperability theme appears elsewhere in the UK. In April 2024, Herefordshire and Worcestershire Health and Care NHS Trust implemented Miya Precision to streamline bed management across seven community hospitals, using Miya Flow and Miya Access while integrating clinical and patient data with the trust’s existing PAS system via the FHIR standard. That project helps make the platform story tangible: Miya is being used not only for long-horizon EPR strategy, but also for operational patient-flow improvement in real clinical settings.
Australia remains an important part of the picture too. Alcidion’s partnership with Leidos Australia and the Commonwealth of Australia continues to expand in Defence, with an earlier extension valued at $8.4 million over 57 months adding Miya Observations and Assessments to the Health Knowledge Management project for the ADF. By Q2 FY26, the company said a further $12.3 million expansion had been secured for additional Miya Precision modules to help Leidos deliver more solution components to the Commonwealth.
That Defence work is strategically important because it shows the platform operating beyond conventional hospital settings. In the ADF environment, Alcidion said Miya Precision was being deployed in settings including Strategic and Tactical Aeromedical Evacuation, reinforcing the flexibility of the modular EPR approach. For a digital-health company, that sort of non-standard clinical environment is a strong proof point.
The company is also continuing to widen its care-delivery relevance. In March 2026, Alcidion signed a contract with Gold Coast Health to implement Miya Precision for remote patient monitoring, enabling the health service to extend virtual care into patients’ homes. The company framed the initiative around reducing unnecessary admissions and freeing up capacity, which aligns closely with how it has been marketing Miya as a smarter-care and patient-flow platform.
Momentum into FY26 has remained encouraging. Alcidion’s Q2 FY26 update said the company had been selected as the preferred supplier by University Hospitals Sussex NHS Foundation Trust for its new EPR solution, with expected total contract value of at least $35 million depending on modules and contract length. The same update also said FY26 contracted revenue, excluding UHSussex, had reached $43.1 million as of 31 December 2025.
The challenge for Alcidion is the one that often accompanies enterprise healthcare software: long sales cycles, complex procurement and the need to execute carefully after large wins. But its recent disclosures suggest the company is navigating that reality from a stronger position than before — with profitability restored, cash on hand, no debt, and multiple significant NHS and Defence relationships now deepening over time rather than remaining one-off announcements.
That is why the partner ecosystem matters so much here. North Cumbria Integrated Care, Mizaic, Leidos Australia, the Commonwealth of Australia, Gold Coast Health, Herefordshire and Worcestershire Health and Care NHS Trust, and now potentially University Hospitals Sussex all show a company being trusted in environments where digital-health systems must work alongside legacy platforms, public procurement and real clinical pressures. Those are hard-earned reference points.
Alcidion now reads like a business that has crossed an important threshold. It is no longer just proving that Miya Precision can be useful; it is proving that the platform can win large, strategic, multi-year roles across the NHS, Australian health systems and Defence. If it continues executing on those wins, Alcidion looks increasingly like one of the more credible digital-health platform stories on the ASX.
